Background-To define the role of metalloproteinases (MMPs) in the development of lipid-rich atherosclerotic lesions in relation to the balance between proteolytic and antiproteolytic activities, we investigated the impact of adenovirusmediated elevation in the circulating levels of human tissue inhibitor of MMP (TIMP-1) in atherosclerosis-susceptible apolipoprotein E-deficient (apoE Ϫ/Ϫ ) mice.
A therosclerosis is a multifactorial, complex pathological process. Cell-cell and cell-matrix interactions involving monocyte-derived macrophages, vascular smooth muscle cells (SMC), endothelial cells, and T-lymphocytes are involved. Extracellular matrix degradation is a key factor in clinical thromboembolic events. Indeed, sudden death caused by acute myocardial infarction frequently results from the rupture of coronary atheroma, particularly at sites of thinning of the lesion's fibrous cap; such rupture results in hemorrhage into the plaque, resulting in a prothrombotic response followed by rapid occlusion of the artery. 1 The accumulation of macrophage-derived foam cells in rupture-prone areas, such as the vulnerable shoulder regions of plaques, 2, 3 correlates with increased local release of matrix-degrading metalloproteinases (MMPs) and weak fibrous cap tissue. 4 These findings suggest a potential role of macrophage-derived MMPs in the fragilization and ultimate rupture of plaque structure. 5, 6 MMPs are a family of enzymes secreted in a latent zymogen form. Interactions between cysteine residues in the propeptide domain and the zinc atom present at the catalytic site of all MMPs are responsible for maintaining the propeptide over the catalytic site. Metalloproteinase activation can occur in vitro or in vivo when the propeptide is cleaved by proteases [7] [8] [9] [10] or when the zinc-cysteine bond is disrupted. 11 The proteolytic capacity of these MMPs together facilitates degradation of many if not all extracellular components present within the fibrous areas of atheromatous plaques. The activity of MMPs can be controlled by specific tissue inhibitors or TIMPs. Three TIMPs (TIMP-1, TIMP-2, and TIMP-3) have been characterized [12] [13] [14] and a fourth (TIMP-4) has been cloned. 15 TIMP-1 is produced by virtually all mesenchymal cells; its cDNA has been cloned and sequenced. 16 TIMP-1 is a secreted glycoprotein with a molecular weight of Ϸ28 kDa stabilized by 6 disulfide bridges. 17 TIMP-1 inhibits all MMPs but has high affinity for MMP-1, MMP-2, MMP-3, and MMP-9. 18 Increased expression of MMPs has been detected in injured arteries and atherosclerotic plaques. Indeed, stromelysin mRNA localize to focal areas enriched in macrophages in human lesions, 19 whereas immunoreactive interstitial collagenase (MMP-1), the 72-kDa gelatinase (MMP-2), stromelysin-1 (MMP-3), and the 92-kDa gelatinase (MMP-9) colocalize to lesional macrophages. 20 In addition, human lipid-laden macrophages prominently express matrilysin (MMP-7) and metalloelastase (MMP-12). 21 These MMPs have a potent capacity to degrade proteoglycans, insoluble elastin, and fibronectin, 22, 23 suggesting that such matrix components are major targets of macrophage-mediated tissue destruction.
Apolipoprotein E (apoE)-deficient mice (apoE Ϫ/Ϫ ) are hypercholesterolemic and develop atherosclerosis spontaneously even when fed a chow diet. Both marked hypercholesterolemia and atherosclerosis are manifest more rapidly in these mice when fed a high-fat, Western-type diet. 24 In such animals, the atherosclerotic lesions present at advanced stages of progression display necrotic cores and are located at the same sites of predilection as human lesions. 25 ApoE Ϫ/Ϫ mice are therefore a relevant animal model in which to identify the complex molecular and cellular mechanisms involved in plaque progression and fragilization.
To define the role of MMPs in relation to the balance between proteolytic and antiproteolytic activities in atherosclerotic lesions, we investigated the impact of elevated circulating levels of human TIMP-1 on the severe atherosclerosis characteristic of hypercholesterolemic apoE Ϫ/Ϫ mice. Overexpression of human TIMP-1 was achieved by adenovirus-mediated gene transfer.
Methods

Generation of Recombinant Adenovirus
Recombinant vectors were constructed on the basis of the pAd.RSV.␤Gal vector by the use of standard techniques. 26 The full-length TIMP-1 cDNA was generated by reverse transcription-polymerase chain reaction from the total RNA of the HL-60 cell line. To optimize initiation of translation, the hybrid intron isolated from the pCI vector (Promega), the untranslated sequence derived from the Xenopus ␤-globin gene, and the Kozak consensus sequence were linked downstream of TIMP-1 cDNA. This fragment was then cloned under the control of the RSV-LTR promoter into the pAd.RSV. vector, into which the bovine growth hormone polyadenylation site from the pRC/CMV plasmid (Invitrogen) had been inserted. The recombinant adenovirus was constructed by in vivo homologous recombination in 293 cells between shuttle plasmids and Ad.RSV.␤Gal and plaque purified. Ad.Empty was constructed with homologous recombination in Escherichia coli. 27 
Cell Transfection Analysis
Human 293 kidney cells (American Type Culture Collection, Rockville, Md) of low passage number were transfected with rAd.RSV.TIMP-1 by use of the calcium phosphate procedure, and TIMP-1 was identified in the culture media by use of an ELISA kit (Amersham) and by immunoblotting with a TIMP-1-monospecific antibody. In addition, use of SDS-PAGE zymography showed human TIMP-1 to inhibit murine MMP activity.
SDS-PAGE Zymography
Tissue from 6-month-old atherosclerotic mouse aortas were used as a source of MMPs. Mouse aortas were homogenized in 1 mL cold buffer containing 0.2% Triton X-100, 50 mmol/L Tris, 10 mmol/L CaCl 2 , and 2 mol/L guanidine hydroxychloride (pH 7.5). The homogenate was centrifuged for 5 minutes at 14 000g. The super- Figure 1 . Experimental design. Ten-week-old female C57BL/6 apoE-deficient mice were fed regular chow diet for 3 weeks. Subsequently they were fed with a chow diet supplemented with 0.2% cholesterol and 10% coconut oil. After 6 weeks, each group of mice was injected in the tail vein with either rAd. RSV.TIMP-1 (1ϫ10 11 vp), rAd.RSV.␤Gal (1ϫ10 11 vp), rAd.CMV.Empty (1ϫ10 11 vp), or PBS (200 L). Blood was drawn once per week from the retro-orbital plexus of each mouse for assay of TIMP-1, lipids, and lipoproteins. Four weeks after treatment, mice were killed and tissues analyzed. natant was extensively dialyzed overnight at 4°C against 0.2% Triton X-100 and 50 mmol/L Tris (pH 7.5) and protein concentration determined. The homogenate (10 g protein) was solubilized in buffer lacking reducing agent and loaded without heating onto a 10% SDS-PAGE containing either 1 mg/mL bovine skin type II gelatin (Sigma) or 1 mg/mL ␣-casein (bovine milk, Sigma) as substrate. The gels were incubated initially in 2.5% Triton-X-100 (2ϫ15 minutes) and subsequently overnight at 37°C in the presence or in the absence of 300 g/mL of recombinant human TIMP-1 (a kind gift from Dr G. Murphy) in 50 mmol/L Tris-HCl, pH 7.4, containing 10 mol/L ZnCl 2 and 0.05% Brij. The gels were then fixed and stained with colloidal brilliant blue G.
Animals
Ten-week-old female C57BL/6 apoE-deficient mice (Transgenic Alliance) were bred and housed at the animal facility of Rhô nePoulenc Rorer (Vitry-sur-Seine, France) under protocols in accordance with French legislation. These mice were fed a regular chow diet and allowed to acclimatize for Ϸ3 weeks and then fed a chow diet supplemented with 0.2% cholesterol and 10% coconut oil. After 6 weeks, the mice were divided into 4 groups. Either rAd.RSV.TIMP-1 (1ϫ10 11 vp), rAd.RSV.␤Gal (1ϫ10 11 vp), rAd.CMV.Empty (1ϫ10 11 vp), or PBS (200 L) was injected into the tail vein of each group of mice. Blood was drawn once per week from the retro-orbital plexus of each mouse for assay of TIMP-1, lipids, and lipoproteins. Four weeks after treatment with either adenoviruses or PBS, the mice were killed and tissues analyzed.
Plasma Lipid and Lipoprotein Analyses
Total cholesterol and triglyceride levels were assayed on fasting plasma (10 L) with the use of enzymatic kits (Biomerieux); HDL cholesterol was measured with dextran sulfate precipitation (Biomerieux) according to the manufacturer's specifications. Plasma lipoproteins were analyzed by fast protein liquid chromatography with 2 Superose 6 columns in series (Pharmacia Biotechnology). Lipoproteins were eluted at a constant flow rate (0.4 mL/min) with PBS buffer containing 1 mmol/L EDTA and 0.02% sodium azide. 28 
Quantification of Plasma TIMP-1 in Mice by ELISA Procedure
Human TIMP-1 in mouse plasma was quantified by a sandwich ELISA kit (Amersham) containing 2 monoclonal antibodies specific to human TIMP-1 antigen.
Quantitative and Qualitative Analysis of Atherosclerotic Plaques
Mice were killed, and freshly-removed hearts were fixed in 10% buffered formalin and then either embedded in paraffin for histological analysis (collagen and elastin staining) or frozen for immunohistochemical studies. Lesion quantification was performed on paraffin sections.
Histological Analysis
Serial paraffin-embedded sections (5 m) were stained with Sirius red or orcein for collagen and elastin visualization, respectively, or stained with hematoxylin, eosin, and saffron for lesion area measurement and the mean lesion area per animal quantified (three 5-m aortic sections, each separated by 100 m). 29
Immunohistochemistry
Frozen serial sections (7 m) were treated with 0.3% H 2 O 2 in PBS to block endogenous peroxidase activity, followed by blocking in 4% BSA (Sigma). Slides were incubated (2 hours at 20°C) with either purified rat monoclonal antibody against mouse macrophages (CD11b antigenϭMac-1) (Valbiotech) at 1:25 dilution (20 g/mL), goat polyclonal antibody against mouse MMP-3 (a generous gift of Dr C. Peeters-Joris, Louvain, Belgium) at 1:300 dilution (40 g/mL), goat polyclonal antibody against mouse MMP-13 (a generous gift of Prof Y. Eeckhout, Louvain, Belgium) at 1:50 dilution (40 g/mL), sheep polyclonal antibody against human MMP-2, which crossreacts with mouse MMP-2 (Valbiotech) at 1:100 dilution (82 g/mL), and a rabbit polyclonal antibody against human TIMP-1 (Euromedex) at 1:1000 dilution (1 g/mL); for ␣-smooth muscle actin studies, a kit (Sigma, ref. IMMH-2) was used. As a negative control, we used either a purified nonimmune IgG from rat, goat, sheep, or rabbit. A second biotinylated antibody was added, either anti-rat at 1:50 dilution, anti-goat, anti-sheep, or anti-rabbit at 1:100, respectively. Thereafter, peroxidase-labeled or alkaline phosphatase-labeled streptavidin was added. The activity of peroxidase was revealed with diaminobenzidine (Merck) as a substrate, yielding a yellow-brown deposit; the substrate for alkaline phosphatase was the fast red substrate system (Dako) yielding an insoluble red reaction product.
Statistical Analysis
The mean surface area of lesions was compared between groups by ANOVA.
Results
Plasma lipoprotein profiles were determined by fast protein liquid chromatography and revealed that HDL predominated with minor amounts of VLDL and LDL in control mice. In Figure 4 . SDS-PAGE zymography. Samples of atherosclerotic aorta from 6-month-old mice were homogenized and extensively dialyzed (see Methods). Aliquots (10 g of protein) were loaded onto 10% SDS-PAGE containing either 1 mg/mL gelatin (A) or 1 mg/mL casein (B) as substrates. MMP activities were determined in the presence (300 g/mL) or absence of recombinant human TIMP-1.
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contrast, VLDL and IDL were prominent in apoE Ϫ/Ϫ mice; HDL levels were significantly diminished (Ϸ5-fold). A similar profile was observed in apoE Ϫ/Ϫ mice when fed the cholesterol-rich diet (data not shown), thereby confirming earlier data. 30 Infusion of apoE Ϫ/Ϫ mice fed the lipid-rich diet ( Figure 1 The recombinant ␤Gal adenovirus construct was used to determine the tissue distribution of adenovirus-mediated gene delivery. Our results (data not shown) confirmed that the liver was the major organ of ␤Gal transgene expression. 31 Plasma lipid and lipoprotein levels in the rAd.RSV.TIMP-1-treated apoE Ϫ/Ϫ mice fed an atherogenic diet as compared with the same mice injected with rAd.RSV.␤Gal, Ad.CMV.Empty, or PBS are summarized in the Table. All parameters increased over the time period but were not statistically different between each group of treated mice.
To determine the effect of TIMP-1 gene expression on the capacity of the cholesterol-rich diet to induce atherosclerosis in apoE Ϫ/Ϫ mice, we infused a subset of 5-month-old mice with either rAd.RSV.TIMP-1, rAd.RSV.␤Gal, rAd.CMV.Empty, or PBS and then killed the animals 4 weeks later (Figure 1) . The rAd.RSV.␤Gal-, rAd.CMV.Empty-, and PBS-infused mice displayed a mean lesion area per section of 750Ϯ182 m 3 (nϭ9 sections from 3 animals), respectively. However, the rAd.RSV.TIMP-1-infused mice exhibited a mean aortic lesion area that was significantly smaller (512Ϯ121 m 2 ϫ10 3 ; nϭ12 sections from 4 animals) than that in animals infused with either rAd.RSV.␤Gal, rAd.CMV.Empty, or PBS PϽ0.05 ( Figure 5) .
To evaluate the impact of TIMP-1 overexpression on the qualitative features of aortic lesions in apoE Ϫ/Ϫ mice fed the lipid-rich diet, we investigated the integrity of collagen, elastin, and ␣-smooth muscle actin, the major constituents of the extracellular matrix of the arterial wall. Four 5-m paraffin sections per animal, starting from the aortic root, each separated by 100 m, were taken from a subset of mice infused with rAd.RSV.TIMP-1, rAd.RSV.␤Gal, rAd.CMV.Empty, or PBS and stained with Sirius red for collagen or with orcein for elastin. For ␣-actin analysis, we used a kit (Sigma, ref. IMMH-2). The results indicated that these 3 matrix proteins were degraded to a lesser degree in the subset of animals treated with rAd.RSV.TIMP-1 as compared with control animals ( Figure 6 , A through F).
The media of the aorta in rAd.RSV.TIMP-1-treated mice was devoid of infiltrating Mac-1-immunoreactive macrophages despite their abundance at the base of the plaque ( Figure 7B) ; by contrast, analyses of rAd.␤Gal-treated mice revealed an accumulation of Mac-1-positive macrophages in an intimal-to-adventitial gradient ( Figure 7A ).
MMP-3 and MMP-13 were detectable in all sections of rAd.RSV.TIMP-1-treated mice as well as in control mice and appeared to colocalize with Mac-1-positive cells (Figure 7 , C through F). In contrast, TIMP-1 antigen was detectable only in rAd.RSV.TIMP-1-treated mice and was uniformly distributed from the intima to the adventitia ( Figure 7, G and H) .
Discussion
The present findings reveal, for the first time, that elevated circulating levels of human TIMP-1 significantly reduce atherosclerotic lesions in atherosclerosis-susceptible hypercholesterolemic apoE Ϫ/Ϫ mice. 
Plasma Lipids and Lipoproteins After Adenovirus-Mediated Gene Transfer of TIMP-1 in ApoE
؊/؊ Mice Day 7  Day 14  Day 21  Day 28   TC  TG  HDL-C  TC  TG  HDL-C  TC  TG  HDL-C  TC  TG  HDL- A rapid (4 weeks) and significant reduction of lesion area (32% vs control; PϽ0.05) occurred in rAd.RSV.TIMP-1-treated mice ( Figure 5) . This reduction appears to result from the local inhibition of the activity of MMPs by human TIMP-1, a protein detected only in the lesions of mice treated with rAd.RSV.TIMP-1 ( Figure 7H ). Human TIMP-1 inhibited murine MMPs in vitro (Figure 4) , a finding consistent with previous work showing that murine MMPs were inhibited in transgenic mice overexpressing human TIMP-1. 32, 33 In addition, MMP-3, MMP-13 ( Figure 7 , C through F), and MMP-2 (data not shown) have been immunolocalized in lesions of our apoE Ϫ/Ϫ mice: one consequence of MMP inhibition might be the limitation of the proteolysis of elastin, collagen, and ␣-actin ( Figure 6, A through F) . Indeed, inhibition of MMPs by local overexpression of TIMP-1 increases elastin accumulation in rat carotid artery intima. 34 Overexpression of TIMPs in neoplastic human 35 and murine 36 cells is associated with decreased MMP activity and reduction in the malignant behavior of these cells. Indeed, MMP overexpression might lead to proliferation and migra- 39 Similarly, adenovirus-mediated gene transfer of TIMP-1 inhibits SMC migration and neointimal formation in human saphenous vein segments in organ culture without effect on SMC proliferation. 40 In this context, our data suggest that the beneficial effect resulting from the overexpression of TIMP-1 might also arise from the inhibition of SMC invasion. In addition, increase in lipid levels with time in rAd.RSV.TIMP-1-treated mice occurred in a manner similar to that in controls. This finding suggests that high levels of human TIMP-1 in murine plasma do not alter lipid metabolism in such a way as to inhibit progression or facilitate lesion regression. Because mice were continuously fed with a cholesterol-rich diet during the adenoviral treatment, the increasing level of TIMP-1 may inhibit the progression of arterial lesions rather than inducing their regression. The reduced number of foam cell-derived macrophages in the lesions of rAd.RSV.TIMP-1-treated mice, in addition to decrease in the dilation of the aortic area as a result of extracellular matrix remodeling, could account for this beneficial effect. A similar observation was reported recently by Carmeliet et al, 10 who established that deficiency of urokinase-type plasminogen in apoE Ϫ/Ϫ mice protects against media destruction and aneurysm formation, probably by means of reduced plasmin-dependent activation of proMMPs. Equally, TIMP-1 may contribute to lesion regression through MMP-induced reduction in HDL-mediated cholesterol efflux from human macrophage foam cells after truncation of the carboxyl terminus of apoA-I. 41 Therefore MMP inhibition by TIMP-1 may protect HDL particles and promote efficient reverse cholesterol transport.
The efficiency of intravascular gene delivery to atherosclerotic lesions may be low because lesions that are frequently rich in connective tissue contain limited numbers of transfectable cells. 42 Nevertheless, high levels of TIMP-1 were observed in lesions treated by rAd.RSV.TIMP-1 in our animal model, and this despite the expression of the irrelevant ␤Gal gene mainly in the liver (data not shown). The localization of TIMP-1 protein in lesions is unlikely to result from transfection of vascular cells but more likely to be attributed to TIMP-1 infiltration across the endothelium. Indeed, TIMP-1 is a stable protein of low molecular weight that may readily infiltrate into the intimal space. Indeed, overexpression of apoIV in murine plasma exerts a protective effect against plaque formation by a mechanism that does not involve increase in HDL cholesterol, 43 suggesting that apoIV infiltrates into the intimal space, where it exerts a protective effect. In addition, adenovirus-mediated overexpression of apoE induces regression of the atherosclerotic lipid core in plaques of apoE Ϫ/Ϫ mice by a mechanism implicating its infiltration and association with lipid present within the intimal area (Duverger et al, personal communication) .
In conclusion, our data prompt the hypothesis that local progression of established atherosclerotic lesions or vulnerable lipid-rich plaques can be retarded by gene transfer techniques. The adenovirus-mediated overexpression of human TIMP-1 in apoE Ϫ/Ϫ mice, an animal model of atherosclerotic plaque formation, provides a convincing example of this therapeutic approach.
